Antiviral activity of Alpinia katsumadai extracts against rotaviruses

Res Vet Sci. 2012 Apr;92(2):320-3. doi: 10.1016/j.rvsc.2010.11.012. Epub 2010 Dec 31.

Abstract

In vitro anti-rotavirus activity of Alpinia katsumadai (AK) extracts were evaluated against bovine G8P[7] and porcine G5P[7] rotaviruses in two different assay strategies, a mixed treatment assay and a post treatment assay. In the mixed treatment assay, six AK extracts [AK-1 (EtOH extract), AK-3 (H(2)O layer), AK-5 (40% methanol fraction), and AK-9-11 (H(2)O extract, polysaccharide fraction, supernatant fraction)] exhibited inhibitory activities against G5P[7] rotavirus with the EC(50) values ranging from 0.7±0.4 to 33.7±6.5 μg/mL. Extracts AK-1, AK-3, and AK-5 inhibited rotavirus infection against G8P[7] rotavirus, the with EC(50) values of 8.4±2.2 μg/mL, 6.5±0.8 μg/mL and 8.4±5.0 μg/mL, respectively. By hemagglutination inhibition (HI) assay, six AK extracts completely inhibited viral adsorption onto human RBCs in both strains of rotaviruses at less than 11 μg/mL. However, in the post treatment assay, there was no anti activity shown against both strains of rotaviruses. As a result, six AK extracts were attributed mainly to having a strong interaction with hemagglutinin protein on the outer surface of rotavirus, resulting to blockage of viral adsorption.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alpinia*
  • Animals
  • Cattle
  • Cattle Diseases / drug therapy
  • Cattle Diseases / virology
  • Hemagglutination Inhibition Tests
  • Macaca mulatta
  • Phytotherapy / methods*
  • Plant Extracts / therapeutic use*
  • Rotavirus / drug effects*
  • Rotavirus Infections / drug therapy
  • Rotavirus Infections / veterinary
  • Seeds
  • Swine
  • Swine Diseases / drug therapy
  • Swine Diseases / virology

Substances

  • Plant Extracts